CSChristina J. Sigurdson

Christina J. Sigurdson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christina J. Sigurdson has a total of 263 co-authors. Here are the top co-authors by number of shared publications:

  • Katrin Soldau

    Department of Pathology and 3Medicine, University of California at San Diego, La Jolla, CA 92093, USA

    14 shared publications
  • Cyrus Bett

    Departments of Pathology and Medicine UC San Diego La Jolla CA

    12 shared publications
  • K. Peter R. Nilsson

    Affiliation Department of Physics, Chemistry, and Biology, Linköping University, Linköping, Sweden

    10 shared publications
  • Timothy D. Kurt

    Departments of Pathology, UC San Diego, La Jolla, CA 92093, USA

    10 shared publications
  • Donald P. Pizzo

    Department of Pathology and 3Medicine, University of California at San Diego, La Jolla, CA 92093, USA

    9 shared publications
  • Patricia Aguilar-Calvo

    Department of Pathology, University of California, San Diego , La Jolla, CA

    8 shared publications

Latest Publications

  • Open Access

    Reduced phosphatases and hyperphosphorylated glutamatergic receptors persist from early to late stages of prion disease

    by Alexander J. Rajic, Daniel Ojeda-Juarez, Dipannita Sarkar, Paige Sumowski, Samantha Flores, Mahsa Pourhamzeh, Katrin Soldau, Donald P. Pizzo, Christina J. Sigurdson

    Synapse loss occurs early in prion disease, yet the intracellular signaling driving this dysregulation remains poorly understood. Evidence of neuronal hyperactivity was reported in humans with sporadic and familial CJD as well as in the early stages of prion disease in mice (strain 22L). Here we perform a time course study of prion-infected mice (strain RML) and show an increase in the immediate-early gene, Arc , suggesting this is a conserved response to prions. We also observed a persistent decrease in phosphatase abundance (PP1α and PP2B) in the cerebral cortex starting at the earliest timepoint (preclinical). At this stage, mGluR5 dimers and phosphorylated AMPA receptors were increased. By clinical disease onset, mGluR5 dimers declined and activity shifted toward NMDA receptor activation, marked by GluN2B hyperphosphorylation. Together, these findings suggest that early phosphatase reduction accompanies neuronal hyperactivity, and precedes substantial inflammation. Elucidating the mechanisms driving this early phosphatase loss and its role in neuronal hyperactivity may reveal novel therapeutic targets for prion disease. Significance statement: Synapse loss and neuronal hyperactivity are early features of prion and Alzheimer’s disease (AD), yet the underlying molecular drivers remain poorly understood. In the current time course study, we reveal elevated levels of neuronal activity protein, Arc, at early, mid, and late timepoints of prion disease. Concurrently, we reveal a persistent and early reduction in key phosphatases (PP1α and PP2B). Additionally, we observed hyperphosphorylation of glutamatergic receptors starting from subclinical stages, before overt neuroinflammation or neuronal loss occur. Furthermore, we uncover a disease-stage-dependent transition from early AMPAR/mGluR5 alterations to late-stage NMDAR involvement. Understanding the mechanisms driving early phosphatase loss and neuronal hyperactivity could reveal novel therapeutic targets for prion disease.

  • Open Access

    Aquaporin-4 mislocalization from astrocyte endfeet prolongs survival in a prion-cerebral amyloid angiopathy model

    by Samantha Flores, Amanda Wilpitz, Daniel Ojeda-Juarez, Jin Wang, Garrett Danque, Paige Sumowski, Gail Funk, Adela Malik, Don Pizzo, Emily Richards, et al.

    Aquaporin 4 (AQP4) water channels are polarized to astrocytic endfeet at blood vessel interfaces, and lose polarity in vascular diseases, including stroke, chronic traumatic encephalopathy, and Alzheimer’s disease. AQP4 modulates water influx and efflux in the interstitial fluid, yet how AQP4 localization impacts cerebral amyloid angiopathy (CAA) remains poorly understood. Here we show that astrocytic end feet and AQP4 are displaced from amyloid-bearing vessels in a prion-CAA mouse model that expresses GPI-anchorless PrP C . Displacing AQP4 genetically through deleting alpha-syntrophin ( Snta1 -/- ) led to a marked prolongation in survival, together with reduced microglial inflammation and C1q, in prion-CAA-affected mice. Additionally, synaptic structural proteins were better maintained. Finally, the level and distribution of prion aggregates were similar among the mice, indicating that prion conversion and spread was not affected. These results suggest that reducing AQP4 water channel function slows the decline in a vascular amyloid disease by reducing neuroinflammation.

  • Open Access

    ESCRT-0 regulates AMPA receptor currents and Ca 2+ - dependent signaling

    by Mahsa Pourhamzeh, Lara Dozier, Amanda Wilpitz, Yixing Du, Daniel B. McClatchy, Mariel K. B. Micael, Joshua E. Mayfield, Stephen K. Gilmore-Hall, Josephina E. Ronson, Katrin Soldau, et al.

    Membrane protein trafficking is essential for synaptic growth, maintenance, function, and plasticity, and involves the regulated exocytosis and endocytosis of proteins to and from the pre-and post-synaptic membranes. Defects in the clearance of membrane proteins can lead to the accumulation of ubiquitinated membrane proteins and contribute to neurodegenerative disease. The ESCRT (endosomal sorting complexes required for transport) machinery binds and sorts ubiquitinated membrane proteins into lysosomes for degradation, yet the presence and function of ESCRTs in sorting ubiquitinated AMPA and other receptors at the post-synapse remain unclear. Here we show that the ubiquitin-binding ESCRT-0 protein, Hrs, localizes to both pre- and post-synapses, and levels are modulated by neuronal activity, increasing and decreasing with higher and lower neuronal activity, respectively. Phosphoproteomic profiling of Hrs-depleted post-synaptic membranes revealed a role for Hrs in glutamatergic synaptic transmission, including long-term potentiation. In addition, Hrs-depleted neurons showed faster AMPAR current kinetics and reduced amplitude in whole-cell patch-clamp recordings. Genetic deletion of neuronal Hgs in mice led to reductions in phosphorylated CaMKII-α and -β (T286/T287) and structural proteins, PSD-95 and gephyrin, suggestive of LTD (long-term depression)-like synaptic depression. In contrast, Hrs overexpression led to increases in Ca 2+ -dependent signaling, including protein kinase C (PKC) and PKC substrate, AMPAR subunit GluA1-S831, a site which increases conductance. Together, these findings identify a dynamic, bidirectional role for Hrs at the post-synapse as it both senses and is modulated by neuronal activity, ultimately impacting excitatory synaptic strength. Significance Statement: Synaptic plasticity relies on dynamic trafficking and turnover of membrane proteins, including AMPA-type glutamate receptors (AMPARs), yet how receptor trafficking intersects with ubiquitin-mediated sorting pathways at synapses remains unclear. We show that the ubiquitin-binding ESCRT-0 protein, Hrs, localizes to both pre- and post-synapses, and its abundance is bidirectionally regulated by neuronal activity. Genetic depletion of Hrs in mice reduces CaMKII phosphorylation and impacts AMPAR channel surface localization. In contrast, neuronal-specific Hrs overexpression led to enhanced GluA1 and protein kinase C substrate phosphorylation, suggesting altered AMPAR trafficking, subunit composition, and/or function. Thus, Hrs emerges as a modulator of glutamatergic signaling, coupling ubiquitin-mediated receptor sorting to the fine-tuning of synaptic transmission, with direct implications for learning and memory in health and disease.

  • Open Access

    PrPC-facilitated cell signaling activates phospholipase Cɣ1 and triggers an Arc/Arg3.1 response in mouse and iPSC-derived human neurons

    by Daniel Ojeda-Juarez, Gail Funk, Daniel B. McClatchy, Emily Richards, Alexander J. Rajic, Katrin Soldau, Michael D. Geschwind, Xu Chen, John R. Yates, Steven L. Gonias, et al.


  • Cellular Prion Protein Engages the N -Methyl- d -Aspartate Receptor through N- and C-Terminal Domains

    by Joshua E. Mayfield, Jin Wang, Hannah Tovell, Susan S. Taylor, Steven L. Gonias, Christina J. Sigurdson

    Nonpathogenic cellular prion protein (PrPC) is expressed by neurons and other cells, regulating neurite outgrowth, cell survival, myelin maintenance, and immunity, yet the PrPC-protein interaction network and signaling pathways that underlie PrPC function remain incompletely understood. PrPC is glycophosphatidylinositol-anchored in lipid rafts and reportedly interacts with membrane-bound proteins at the cell surface, including the N-methyl-d-aspartate receptor (NMDA-R), triggering cell-signaling responses. PrPC may also be glycosylphosphatidylinositol (GPI)-anchored in extracellular vesicles or released from cells by proteases to interact with plasma membrane proteins in target cells. To identify PrPC binding sites for the NMDA-R in an unbiased manner, we generated extracts from HEK293T cells transfected with the GluN1 and GluN2B NMDA-R subunits and performed a targeted series of co-immunoprecipitation experiments, peptide arrays, and protein structure analyses. We identified two sites in PrPC that bind to the NMDA-R. One site was located in the N-terminal disordered region of PrPC. This site is in a lysine-rich segment that incorporates the sequence previously identified as the biologically active PrPC-derived peptide, P3. The second site was located in the C-terminal structured region of PrPC within the α1 helix and β1 strand. PrPC bound GluN1-GluN2B complexes as well as GluN1 in isolation. Notably, the N-linked glycans in PrPC inhibited binding to GluN1. Mutation of PrPC to incorporate a third glycosylation site further inhibited binding to GluN1. These results demonstrate binding sites in PrPC that may mediate interaction with the NMDA-R when PrPC is membrane-anchored to the cell of origin, released in extracellular vesicles, or shed from the cell surface by proteases.

  • Open Access

    Correction for Ligios et al., “Sheep with Scrapie and Mastitis Transmit Infectious Prions through the Milk”

    by Ciriaco Ligios, Maria Giovanna Cancedda, Antonello Carta, Cinzia Santucciu, Caterina Maestrale, Francesca Demontis, Mariangela Saba, Cristiana Patta, James C. DeMartini, Adriano Aguzzi, et al.


  • Open Access

    Strain-Dependent Susceptibility to Prion Infection Encoded by Arg171 and Lys176 Sheep Prion Protein Polymorphic Variants

    by Juan Carlos Espinosa, Natalia Fernández-Borges, Alba Marín-Moreno, Sara Canoyra, Patricia Aguilar-Calvo, Belén Pintado, Eva Pericuesta, Sylvie L Benestad, Romolo Nonno, Olivier Andréoletti, et al.

    Background: Classical scrapie in sheep is caused by several different strains rather than a single strain, as is the case for epidemic classical bovine spongiform encephalopathy (BSE). Polymorphisms R171 and K176 located in the β2-α2 loop region of sheep prion protein (PrP) have been associated with potential protection for the propagation of classical scrapie. Methods: The protective role of R171 and K176 polymorphic variants in susceptibility and resistance to different prion strains circulating in Europe was investigated using transgenic mouse lines expressing R171 or K176 sheep PrP in comparable levels (R171-Tg552 and K176-Tg570, respectively). Both lines were intracranially challenged with a panel of isolates representative of diverse prion strains, including at least 4 different classical scrapie strains. These isolates were previously characterized by transmission studies in ovine (Wt-OvPrP-Tg501) and bovine (BoPrP-Tg110) transgenic mice. Results: R171-Tg552 and K176-Tg570 mouse lines succumbed after the inoculation of atypical scrapie isolates with 100% attack rates and long survival times. However, the propagation of all tested classical scrapie isolated was completely blocked in R171-Tg552 mice, whereas in K176-Tg570 mice the propagation of most of the classical scrapie isolates was highly restricted or completely blocked depending on the prion strain. BSE transmission to R171-Tg552 mice was only possible after its adaptation to sheep PrP while no infection could be detected in K176-Tg570 mice, even after passage in sheep. Conclusions: These results indicate that the R171 and K176 polymorphic variants of the ovine PrP sequence restrict the propagation of prions in a strain-dependent manner and are useful tools for prion strain discrimination.

  • Open Access

    PrP C -induced signaling in human neurons activates phospholipase Cɣ1 and an Arc/Arg3.1 response

    by Daniel Ojeda-Juarez, Gail Funk, Emily Richards, Alexander J. Rajic, Daniel B. McClatchy, Katrin Soldau, Xu Chen, John R. Yates, Steven L. Gonias, Christina J. Sigurdson

    Synaptic dysfunction and loss correlate with cognitive decline in neurodegenerative diseases, including Alzheimer’s disease (AD) and prion disease. Neuronal hyperexcitability occurs in the early stages of AD and experimental prion disease, prior to the onset of dementia, yet the underlying drivers are unclear. Here we identify an increase in the immediate early gene, Arc/Arg3.1, in the human prion disease-affected frontal cortex, suggestive of neuronal hyperactivity. To investigate early signaling events initiated by prion aggregates (PrP Sc ) in human neurons, we stimulated PrP C in human iPSC-derived excitatory neurons (iNs) with a known PrP Sc -mimetic antibody (POM1), which recapitulated the Arc/Arg3.1 response within two hours. Proteomics, RNAseq, and a phosphokinase array in iNs revealed alterations in the EGF receptor and increased phosphorylated phospholipase C (PLC)-γ1 (Y783), which was also observed in the cerebral cortex of prion-infected mice. Thus, PrP C ligands can induce a PLC-γ1 intracellular signaling cascade together with an Arc response, suggestive of a neuronal activity response.


  • Open Access

    Mutant prion protein enhances NMDA receptor activity, activates PKC, and triggers rapid excitotoxicity in mice

    by Joie Lin, Julia A. Callender, Joshua E. Mayfield, Daniel B. McClatchy, Daniel Ojeda-Juárez, Mahsa Pourhamzeh, Katrin Soldau, Timothy D. Kurt, Garrett A. Danque, Helen K. Khuu, et al.

    Neuronal hyperexcitability precedes synapse loss in certain neurodegenerative diseases, yet the synaptic membrane interactions and downstream signaling events remain unclear. The disordered amino terminus of the prion protein (PrP C ) has been implicated in aberrant signaling in prion and Alzheimer’s disease. To disrupt neuronal interactions and signaling linked to the amino terminus, we CRISPR-engineered a knockin mouse expressing mutant PrP C (G92N), generating an N -linked glycosylation site between 2 functional motifs. Mice developed seizures and necrosis of hippocampal pyramidal neurons, similar to prion-infected mice and consistent with excitotoxicity. Phosphoproteomics analysis revealed phosphorylated glutamate receptors and calcium-sensitive kinases, including protein kinase C (PKC). Additionally, 92N-PrP C -expressing neurons showed persistent calcium influx as well as dendritic beading, which was rescued by an N -methyl-d-aspartate receptor (NMDAR) antagonist. Finally, survival of Prnp 92N mice was prolonged by blocking active NMDAR channels. We propose that dysregulated PrP C -NMDAR–induced signaling can trigger an excitatory-inhibitory imbalance, spongiform degeneration, and neurotoxicity and that calcium dysregulation is central to PrP C -linked neurodegeneration.


  • Open Access

    Multi-omic analysis of meningeal cerebral amyloid angiopathy reveals enrichment of unsubstituted glucosamine and extracellular proteins

    by Joshua E Mayfield, Alexander J Rajic, Patricia Aguilar-Calvo, Katrin Soldau, Samantha Flores, Roger Lawrence, Biwsa Choudhury, Majid Ghassemian, Donald P Pizzo, Steven L Wagner, et al.

    Cerebral amyloid angiopathy (CAA) is a common feature of Alzheimer’s disease in which amyloid-β (Aβ) deposits in cerebral and leptomeningeal vessel walls, predisposing vessels to micro- and macro-hemorrhages. The vessel walls contain distinct proteins and heparan sulfate (HS), yet how vascular proteins and HS jointly associate with Aβ is unknown. We conducted the first multi-omics study to systematically characterize the proteins as well as the HS abundance, sulfation level, and disaccharide composition of leptomeninges from 23 moderate to severe CAA cases and controls. We then analyzed the associations between Aβ and other proteins, HS, and apolipoprotein E genotype. We found an increase in a minor HS disaccharide containing unsubstituted glucosamine, as well as 6-O sulfated disaccharides; Aβ40 levels positively correlated with unsubstituted glucosamine. There was also an increase in extracellular proteins derived from brain parenchyma or plasma, including olfactomedin-like protein 3, fibrinogen, serum amyloid protein, apolipoprotein E, and secreted frizzled related protein-3. Our findings of vascular HS and protein alterations specific to CAA-affected leptomeningeal vessels provide molecular insight into the extracellular remodeling that co-occurs with Aβ deposits and may indicate a basis for antemortem diagnostic assay development and therapeutic strategies to impede Aβ-HS interactions.